Reprocell Europe Ltd.

https://www.reprocell.com

REPROCELL Europe was created on the 1st of July 2016 from the merger of Biopta Ltd and Reinnervate Ltd. REPROCELL Europe offers the full range of life sciences research products and contract research services of the REPROCELL Group Brands (REPROCELL, Biopta, Reinnervate, Stemgent and BioServe) to markets worldwide. Through the ongoing research and development synergies within the Group, REPROCELL Europe aims to bring to market further unique products and services to accelerate research in stem cells, drug discovery, human tissues and 3D cell culture. *

	Start	2016-07-01 merged
	Predecessor	Reinnervate Ltd.
	Industry	cell culture system
	Industry 2	Alvetex® Scaffold 3D cell culturing technology
	Person	Cooper, Ashley (Reinnervate 200709– CEO)

	City	n. a.
		Address record changed: 2021-08-10

Basic data	Employees	n. a.

		* Document for »About Section«: Roslin Cell Therapies Ltd. (RoslinCT). (10/10/18). "Press Release: RoslinCT and Reprocell Awarded £1.2 Million Project from Innovate UK for Clinical-grade Stem Cell Production". Edinburgh & Glasgow.

		Record changed: 2023-07-10

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)